Views: 0 Author: Site Editor Publish Time: 2025-10-25 Origin: Site
A Complete Guide to Their Applications & Key Differences
Pre-filled syringe (PFS) injection pens have become one of the most popular delivery systems in modern biopharmaceuticals. With simple operation, high precision, and excellent compatibility with peptide and biologic formulations, they are widely used in weight-management therapies, chronic-disease treatment, and specialty medications.
Among all formats, the 1.0 mL PFS injection pen and 2.25 mL PFS injection pen are the two most commonly used specifications.
But what medications does each size support?
And what are the functional differences between them?
This article provides a clear, professional comparison to help pharmaceutical companies, clinics, and distributors choose the right device.
A PFS (Pre-Filled Syringe) Injection Pen is a reusable or disposable pen designed to deliver medication that is pre-filled inside a glass or plastic syringe.
It allows:
Accurate dosage delivery
Stable injection force
Convenient self-administration
High medication compatibility (especially for peptides, GLP-1 drugs, hormones, and biologics)
PFS pens are commonly used with 1 mL or 2.25 mL pre-filled syringes—these two sizes cover most of today's popular injectable drugs.
The 1.0 mL PFS injection pen is the standard and most widely used specification.
It is suitable for medications requiring low to medium dosage and frequent injections.
Semaglutide (Ozempic)
Liraglutide (Saxenda)
Dulaglutide low-dose formulations
Growth hormones (GH)
Fertility medications (FSH, HCG)
Testosterone or estrogen micro-dose therapies
Insulin
Multiple sclerosis drugs
Osteoporosis injections (daily use)
Skin-boosting peptides
Aesthetic clinic formulations
Why 1 mL?
1 mL syringes support smaller, more frequent dosages and shorter pen strokes, which make injections smoother and easier.
The 2.25 mL PFS injection pen is a newer specification designed to meet the growing demand for higher-dose, longer-interval medications, especially in the GLP-1 market.
Semaglutide high-dose
Tirzepatide (Mounjaro / Zepbound)
New dual/triple agonists in pipeline
Once-weekly or once-monthly peptide treatments
Anti-inflammatory biologics
Monoclonal antibodies
Immunology drugs
Why 2.25 mL?
Manufacturers are increasing drug concentration and volume to reduce injection frequency.
A larger syringe volume allows a single injection to deliver more active substance while maintaining patient comfort.
| Feature | 1.0 mL PFS Pen | 2.25 mL PFS Pen |
|---|---|---|
| Typical use | Small-dose, frequent injections | High-dose, less frequent injections |
| Common drugs | Insulin, GH, FSH, low-dose GLP-1 | Tirzepatide, high-dose GLP-1, biologics |
| Dosage increments | Smaller, fine-tuned increments | Medium increments, higher capacity |
| Injection force | Low | Higher — pen must support stable force |
| Target market | Daily or weekly injections | Weekly or monthly injections |
| User profile | Diabetes, fertility, cosmetic | Weight loss, chronic disease, biologics |
| Pen design | Shorter stroke, compact | Longer stroke, stronger mechanism |
Simply put:
When choosing a PFS injection pen, manufacturers and clinics should consider:
✔ The viscosity and stability of the drug
✔ Dosage volume per injection
✔ Frequency of patient usage
✔ Required dosage increments
✔ Compatibility with 1 mL or 2.25 mL syringes
✔ Certification & regulatory requirements
Our PFS pen solutions support both 1.0 mL and 2.25 mL syringes, customizable for:
Drug viscosity
Patient force threshold
Dosage scale
Housing color
OEM branding
Clinical trial batches
1 mL and 2.25 mL PFS injection pens each serve a distinct purpose in modern drug delivery.
As the pharmaceutical industry shifts toward high-dose weekly or monthly injections—especially in the booming weight-management sector—the demand for 2.25 mL pens is rapidly increasing.
Meanwhile, 1 mL pens remain the gold standard for precision dosing, daily use, and hormone therapy.
Choosing the right device ensures medication safety, consistent injection performance, and a better patient experience.